Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors

T. S. Udayakumar, Russell D. Klein, M. Suzanne Maliner, Raymond B Nagle, G. T. Bowden

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins, and there is evidence that they play a role in tumor cell growth, invasion and metastasis. Matrilysin (MMP-7) is over-expressed in prostate cancer cells and increases prostate cancer cell invasion. Prostate stromal fibroblasts secrete a factor(s), including fibroblast growth factor-I (FGF-I), which induces promatrilysin expression in the prostate carcinoma cell line LNCaP but not in normal prostate epithelial cells (PrECs). Since FGF-I is present in the prostate, an altered sensitivity to FGF-I might explain the up regulation of matrilysin expression in prostate cancer cells compared to normal prostate epithelium. FGF receptor-I (FGFR-I) is not normally expressed by normal prostate epithelial cells; however, aberrant expression of this receptor has been reported in prostate cancer cells, including the LNCaP cell line. We hypothesized that aberrant expression of FGFR-I in PrECs would render them sensitive to induction of promatrilysin expression by recombinant FGF-I. To test this hypothesis, we transiently transfected PrECs with an FGFR-I expression vector, which resulted in over-expression of FGFR-I protein in approximately 40% of cells. FGF-I increased promatrilysin expression in FGFR-I-transfected PrECs 4-fold over mock-transfected cells, and this induction was inhibited by a specific FGFR-I inhibitor, SU5402, and by co-expression of a dominant negative FGFR-I protein. Our results demonstrate that aberrant FGFR-I expression, an epigenetic phenomenon that has been associated with prostate cancer progression, allows induction of promatrilysin expression by FGF-I in PrECs.

Original languageEnglish (US)
Pages (from-to)187-192
Number of pages6
JournalInternational Journal of Cancer
Volume91
Issue number2
StatePublished - Jan 15 2001

Fingerprint

Receptor, Fibroblast Growth Factor, Type 1
Fibroblast Growth Factors
Fibroblast Growth Factor Receptors
Prostate
Epithelial Cells
Matrix Metalloproteinase 7
Prostatic Neoplasms
promatrilysin
Cell Line
Extracellular Matrix Proteins
Matrix Metalloproteinases
Epigenomics
Proteins
Up-Regulation
Epithelium
Fibroblasts

Keywords

  • Fibroblast growth factor
  • LNCaP
  • Matrilysin
  • PrEc
  • Prostate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors. / Udayakumar, T. S.; Klein, Russell D.; Maliner, M. Suzanne; Nagle, Raymond B; Bowden, G. T.

In: International Journal of Cancer, Vol. 91, No. 2, 15.01.2001, p. 187-192.

Research output: Contribution to journalArticle

@article{b2ffc87c63a0481e9944c20bf265a0f1,
title = "Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors",
abstract = "Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins, and there is evidence that they play a role in tumor cell growth, invasion and metastasis. Matrilysin (MMP-7) is over-expressed in prostate cancer cells and increases prostate cancer cell invasion. Prostate stromal fibroblasts secrete a factor(s), including fibroblast growth factor-I (FGF-I), which induces promatrilysin expression in the prostate carcinoma cell line LNCaP but not in normal prostate epithelial cells (PrECs). Since FGF-I is present in the prostate, an altered sensitivity to FGF-I might explain the up regulation of matrilysin expression in prostate cancer cells compared to normal prostate epithelium. FGF receptor-I (FGFR-I) is not normally expressed by normal prostate epithelial cells; however, aberrant expression of this receptor has been reported in prostate cancer cells, including the LNCaP cell line. We hypothesized that aberrant expression of FGFR-I in PrECs would render them sensitive to induction of promatrilysin expression by recombinant FGF-I. To test this hypothesis, we transiently transfected PrECs with an FGFR-I expression vector, which resulted in over-expression of FGFR-I protein in approximately 40{\%} of cells. FGF-I increased promatrilysin expression in FGFR-I-transfected PrECs 4-fold over mock-transfected cells, and this induction was inhibited by a specific FGFR-I inhibitor, SU5402, and by co-expression of a dominant negative FGFR-I protein. Our results demonstrate that aberrant FGFR-I expression, an epigenetic phenomenon that has been associated with prostate cancer progression, allows induction of promatrilysin expression by FGF-I in PrECs.",
keywords = "Fibroblast growth factor, LNCaP, Matrilysin, PrEc, Prostate",
author = "Udayakumar, {T. S.} and Klein, {Russell D.} and Maliner, {M. Suzanne} and Nagle, {Raymond B} and Bowden, {G. T.}",
year = "2001",
month = "1",
day = "15",
language = "English (US)",
volume = "91",
pages = "187--192",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors

AU - Udayakumar, T. S.

AU - Klein, Russell D.

AU - Maliner, M. Suzanne

AU - Nagle, Raymond B

AU - Bowden, G. T.

PY - 2001/1/15

Y1 - 2001/1/15

N2 - Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins, and there is evidence that they play a role in tumor cell growth, invasion and metastasis. Matrilysin (MMP-7) is over-expressed in prostate cancer cells and increases prostate cancer cell invasion. Prostate stromal fibroblasts secrete a factor(s), including fibroblast growth factor-I (FGF-I), which induces promatrilysin expression in the prostate carcinoma cell line LNCaP but not in normal prostate epithelial cells (PrECs). Since FGF-I is present in the prostate, an altered sensitivity to FGF-I might explain the up regulation of matrilysin expression in prostate cancer cells compared to normal prostate epithelium. FGF receptor-I (FGFR-I) is not normally expressed by normal prostate epithelial cells; however, aberrant expression of this receptor has been reported in prostate cancer cells, including the LNCaP cell line. We hypothesized that aberrant expression of FGFR-I in PrECs would render them sensitive to induction of promatrilysin expression by recombinant FGF-I. To test this hypothesis, we transiently transfected PrECs with an FGFR-I expression vector, which resulted in over-expression of FGFR-I protein in approximately 40% of cells. FGF-I increased promatrilysin expression in FGFR-I-transfected PrECs 4-fold over mock-transfected cells, and this induction was inhibited by a specific FGFR-I inhibitor, SU5402, and by co-expression of a dominant negative FGFR-I protein. Our results demonstrate that aberrant FGFR-I expression, an epigenetic phenomenon that has been associated with prostate cancer progression, allows induction of promatrilysin expression by FGF-I in PrECs.

AB - Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins, and there is evidence that they play a role in tumor cell growth, invasion and metastasis. Matrilysin (MMP-7) is over-expressed in prostate cancer cells and increases prostate cancer cell invasion. Prostate stromal fibroblasts secrete a factor(s), including fibroblast growth factor-I (FGF-I), which induces promatrilysin expression in the prostate carcinoma cell line LNCaP but not in normal prostate epithelial cells (PrECs). Since FGF-I is present in the prostate, an altered sensitivity to FGF-I might explain the up regulation of matrilysin expression in prostate cancer cells compared to normal prostate epithelium. FGF receptor-I (FGFR-I) is not normally expressed by normal prostate epithelial cells; however, aberrant expression of this receptor has been reported in prostate cancer cells, including the LNCaP cell line. We hypothesized that aberrant expression of FGFR-I in PrECs would render them sensitive to induction of promatrilysin expression by recombinant FGF-I. To test this hypothesis, we transiently transfected PrECs with an FGFR-I expression vector, which resulted in over-expression of FGFR-I protein in approximately 40% of cells. FGF-I increased promatrilysin expression in FGFR-I-transfected PrECs 4-fold over mock-transfected cells, and this induction was inhibited by a specific FGFR-I inhibitor, SU5402, and by co-expression of a dominant negative FGFR-I protein. Our results demonstrate that aberrant FGFR-I expression, an epigenetic phenomenon that has been associated with prostate cancer progression, allows induction of promatrilysin expression by FGF-I in PrECs.

KW - Fibroblast growth factor

KW - LNCaP

KW - Matrilysin

KW - PrEc

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=0035863564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035863564&partnerID=8YFLogxK

M3 - Article

C2 - 11146443

AN - SCOPUS:0035863564

VL - 91

SP - 187

EP - 192

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -